{"id":358006,"date":"2025-08-29T11:26:58","date_gmt":"2025-08-29T11:26:58","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-prothena-corporation\/"},"modified":"2025-08-29T11:26:58","modified_gmt":"2025-08-29T11:26:58","slug":"how-to-buy-prothena-corporation","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/","title":{"rendered":"Prothena Corporation plc (PRTA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Prothena Corporation plc (PRTA) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334036,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-358006","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Prothena Corporation plc (PRTA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Prothena Corporation plc (PRTA) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Prothena Corporation plc (PRTA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Prothena Corporation plc (PRTA) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Prothena Corporation plc (PRTA) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 tam yat\u0131r\u0131m analizimizle \u00f6\u011frenin. Bu biyoteknoloji hissesi i\u00e7in g\u00fcncel fiyat, riskler ve b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Prothena Corporation plc (PRTA) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 tam yat\u0131r\u0131m analizimizle \u00f6\u011frenin. Bu biyoteknoloji hissesi i\u00e7in g\u00fcncel fiyat, riskler ve b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"\u0130leri teknoloji biyoteknolojiye yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Prothena Corporation plc (PRTA), n\u00f6rodejeneratif hastal\u0131k tedavilerinin gelece\u011fine eri\u015fmek i\u00e7in b\u00fcy\u00fcleyici bir f\u0131rsat sunuyor. Bu \u0130rlanda-Amerikan biyofarma \u015firketi, Alzheimer, Parkinson ve nadir amiloid hastal\u0131klar\u0131n\u0131 hedef alan yenilik\u00e7i \u00fcr\u00fcn hatt\u0131yla dikkat \u00e7ekiyor. PRTA'n\u0131n neden bir sonraki stratejik yat\u0131r\u0131m hamleniz olabilece\u011fini birlikte ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"\u0130leri teknoloji biyoteknolojiye yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Prothena Corporation plc (PRTA), n\u00f6rodejeneratif hastal\u0131k tedavilerinin gelece\u011fine eri\u015fmek i\u00e7in b\u00fcy\u00fcleyici bir f\u0131rsat sunuyor. Bu \u0130rlanda-Amerikan biyofarma \u015firketi, Alzheimer, Parkinson ve nadir amiloid hastal\u0131klar\u0131n\u0131 hedef alan yenilik\u00e7i \u00fcr\u00fcn hatt\u0131yla dikkat \u00e7ekiyor. PRTA'n\u0131n neden bir sonraki stratejik yat\u0131r\u0131m hamleniz olabilece\u011fini birlikte ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 Prothena Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2> <p>29 A\u011fustos 2025 itibar\u0131yla Prothena Corporation (PRTA), NASDAQ borsas\u0131nda <strong>8,24 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>11 Kas\u0131m 2025<\/strong> kesinlikle kritik\u2014Prothena'n\u0131n 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih. Tarihsel olarak, bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden oluyor.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 PRTA Hissesini Nas\u0131l Etkiler?<\/h3> <table> <thead> <tr> <th>Tarih<\/th> <th>Olay<\/th> <th>Haber \u00d6ncesi Fiyat<\/th> <th>Haber Sonras\u0131 De\u011fi\u015fim<\/th> <\/tr> <\/thead> <tbody> <tr> <td>4 A\u011fu 2025<\/td> <td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td> <td>6,81 $<\/td> <td>+%1,3 (ertesi g\u00fcn)<\/td> <\/tr> <tr> <td>8 May 2025<\/td> <td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td> <td>5,92 $<\/td> <td>+%8,2 (bir hafta sonra)<\/td> <\/tr> <tr> <td>20 \u015eub 2025<\/td> <td>4. \u00c7eyrek Kazan\u00e7lar\u0131<\/td> <td>7,15 $<\/td> <td>-%4,1 (beklentiler kar\u015f\u0131lanmad\u0131)<\/td> <\/tr> <tr> <td>12 Kas 2024<\/td> <td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td> <td>8,40 $<\/td> <td>+%12,7 (beklentiler a\u015f\u0131ld\u0131)<\/td> <\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Prothena, kazan\u00e7 beklentileri kar\u015f\u0131lanmad\u0131\u011f\u0131nda bile (\u00f6rne\u011fin 2025 2. \u00e7eyrek -%13,82 sapma) yat\u0131r\u0131mc\u0131lar\u0131n klinik \u00fcr\u00fcn hatt\u0131na olan iyimserli\u011fi sayesinde genellikle h\u0131zl\u0131 toparlanma g\u00f6steriyor.<\/p> <h3>6 Ayl\u0131k Fiyat Seyri (Mart-A\u011fustos 2025)<\/h3> <p>Prothena hisseleri son d\u00f6rt haftada <strong>%29,7<\/strong> art\u0131\u015fla adeta bir h\u0131z treni ya\u015fad\u0131:<\/p> <ul> <li><strong>Mart 2025<\/strong>: 5,20 $ (k\u0131\u015f sonras\u0131 konsolidasyon)<\/li> <li><strong>May\u0131s 2025<\/strong>: 6,50 $ (1. \u00e7eyrek kazan\u00e7 beklentisi)<\/li> <li><strong>Temmuz 2025<\/strong>: 6,30 $ (yaz volatilitesi)<\/li> <li><strong>A\u011fustos 2025<\/strong>: 8,24 $ (klinik deneme iyimserli\u011fi)<\/li> <\/ul> <p><strong>Son y\u00fckseli\u015fin sebebi nedir?<\/strong> \u015eirket, Alzheimer ilac\u0131 PRX012 i\u00e7in umut verici Faz 1 sonu\u00e7lar\u0131n\u0131 a\u00e7\u0131klad\u0131 ve Novo Nordisk ile ileri a\u015fama denemeler i\u00e7in b\u00fcy\u00fck bir ortakl\u0131k taahh\u00fcd\u00fc sa\u011flad\u0131.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p><strong>2025 (Y\u0131l Sonu)<\/strong>: 22-25 $ (klinik d\u00f6n\u00fcm noktalar\u0131 ger\u00e7ekle\u015fmesi) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br\/> <strong>2026<\/strong>: 30-35 $ (ortakl\u0131k gelirlerinin tan\u0131nmas\u0131)<br\/> <strong>2028<\/strong>: 45-55 $ (muhtemel ilk ticari onaylar)<br\/> <strong>2030<\/strong>: 70+ $ (\u00fcr\u00fcn hatt\u0131n\u0131n olgunla\u015fmas\u0131 ve pazar geni\u015flemesi)<\/p> <p><strong>Sonu\u00e7<\/strong>: Bu klasik bir biyoteknoloji f\u0131rsat\u0131\u2014y\u00fcksek risk ama sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in ola\u011fan\u00fcst\u00fc \u00f6d\u00fcl potansiyeli.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Deneysel ila\u00e7lar\u0131n %90\u2019\u0131 piyasaya ula\u015fam\u0131yor<\/li> <li><strong>Nakit t\u00fcketimi<\/strong>: Y\u0131ll\u0131k 302 milyon $ zarar, s\u0131k fonlama gerektiriyor<\/li> <li><strong>Reg\u00fclasyon engelleri<\/strong>: FDA onaylar\u0131 y\u0131llar alabilir ve beklenmedik gecikmeler ya\u015fanabilir<\/li> <li><strong>Hisse seyrelmesi<\/strong>: Gelecekteki fonlamalar mevcut hissedarlar\u0131 seyreltebilir<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Novo Nordisk ortakl\u0131\u011f\u0131<\/strong>: \u0130la\u00e7lar\u0131 ileri a\u015fama denemelere ta\u015f\u0131ma taahh\u00fcd\u00fc (<a href=\"https:\/\/ir.prothena.com\/investors\/press-releases\/news-details\/2025\/Prothena-Announces-Corporate-Restructuring\/default.aspx\">Kurumsal Yeniden Yap\u0131lanma Duyurusu<\/a>)<\/li> <li><strong>PRX012 at\u0131l\u0131m\u0131<\/strong>: Faz 1 Alzheimer verileri umut veriyor (<a href=\"https:\/\/ir.prothena.com\/investors\/press-releases\/news-details\/2025\/Prothena-Provides-Update-on-PRX012-and-Announces-Results-from-the-Phase-1-ASCENT-Clinical-Program\/default.aspx\">ASCENT Klinik Program\u0131<\/a>)<\/li> <li><strong>Analist iyimserli\u011fi<\/strong>: Ortalama fiyat hedefi 30,25 $ ile %267 y\u00fckseli\u015f potansiyeli (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/PRTA\/forecast\/\">MarketBeat Analizi<\/a>)<\/li> <li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: N\u00f6rodejeneratif hastal\u0131k pazar\u0131 2028\u2019de 50 milyar $\u2019a ula\u015fmas\u0131 bekleniyor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn sadece %2-3\u2019\u00fcn\u00fc y\u00fcksek riskli biyoteknoloji hisselerine ay\u0131r\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Birka\u00e7 ay boyunca 100-200 $ aras\u0131 al\u0131mlar yap\u0131n<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Daha iyi giri\u015f i\u00e7in 7,50 $ alt\u0131ndaki d\u00fc\u015f\u00fc\u015fleri takip edin<\/li> <li><strong>Esprili yakla\u015f\u0131m<\/strong>: \"PRTA ticareti yapmak, dahi bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014y\u0131ld\u00f6n\u00fcm\u00fcn\u00fcz\u00fc unutabilirler ama bir sonraki penisilini ke\u015ffedebilirler!\"<\/li> <\/ol> <h2>\u2705 Prothena Corporation plc (PRTA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr> <th>Ad\u0131m<\/th> <th>\u0130\u015flem<\/th> <th>Neden \u00d6nemli<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Bir ticaret platformu se\u00e7in<\/td> <td>NASDAQ listeleri ve par\u00e7al\u0131 hisse sunmas\u0131na dikkat edin<\/td> <\/tr> <tr> <td>2<\/td> <td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td> <td>Genellikle 1-2 i\u015f g\u00fcn\u00fc s\u00fcrer<\/td> <\/tr> <tr> <td>3<\/td> <td>Fon yat\u0131r\u0131n<\/td> <td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td> <\/tr> <tr> <td>4<\/td> <td>\"PRTA\" aramas\u0131 yap\u0131n<\/td> <td>Sadece \"Prothena\" de\u011fil, sembol\u00fc kullan\u0131n<\/td> <\/tr> <tr> <td>5<\/td> <td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td> <td>Limit emirleri volatilite s\u0131ras\u0131nda a\u015f\u0131r\u0131 \u00f6deme yapman\u0131z\u0131 engeller<\/td> <\/tr> <tr> <td>6<\/td> <td>\u0130nceleyin ve onaylay\u0131n<\/td> <td>Komisyon \u00fccretlerini kontrol edin\u2014%1\u2019in alt\u0131nda hedefleyin<\/td> <\/tr> <tr> <td>7<\/td> <td>Pozisyonunuzu izleyin<\/td> <td>Al\u0131\u015f fiyat\u0131n\u0131n %20-25 alt\u0131nda stop-loss koyun<\/td> <\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in \u00dcst\u00fcn?<\/h2> <p>Pocket Option, inan\u0131lmaz eri\u015filebilir yakla\u015f\u0131m\u0131yla \u00f6ne \u00e7\u0131k\u0131yor: <strong>sadece 5 $ minimum depozito<\/strong> ile stratejilerinizi risksiz test etmenizi sa\u011fl\u0131yor. Platform, <strong>1 dakikal\u0131k KYC do\u011frulamas\u0131<\/strong> sunuyor ve tek bir belge ile yap\u0131labiliyor. Ayr\u0131ca <strong>100\u2019den fazla para \u00e7ekme y\u00f6ntemi<\/strong> destekliyor; kripto paralar, e-c\u00fczdanlar ve geleneksel banka transferleri dahil. Bu esneklik, PRTA gibi volatil biyoteknoloji hisselerinde k\u00fc\u00e7\u00fck ba\u015flay\u0131p b\u00fcy\u00fcmek isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in ideal.<\/p> <h2>\ud83c\udf0d 2025\u2019te Prothena: N\u00f6robilimde Yenilik\u00e7i<\/h2> <p>Prothena Corporation, protein d\u00fczensizli\u011fi uzmanl\u0131\u011f\u0131yla n\u00f6rodejeneratif hastal\u0131k tedavisinde devrim yarat\u0131yor. \u015eirket, Alzheimer, Parkinson ve nadir amiloid hastal\u0131klar\u0131na odaklan\u0131yor ve Bristol Myers Squibb ile Novo Nordisk gibi b\u00fcy\u00fck ila\u00e7 firmalar\u0131yla stratejik ortakl\u0131klar kuruyor.<\/p> <p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025\u2019te Prothena ara\u015ft\u0131rma ekibi, Alzheimer hastalar\u0131nda belirli protein katlanma bozukluklar\u0131n\u0131n origami yap\u0131lar\u0131 gibi oldu\u011funu ke\u015ffetti\u2014bu da \"protein origami\" ad\u0131 verilen yeni bir ara\u015ft\u0131rma yakla\u015f\u0131m\u0131na yol a\u00e7t\u0131 ve d\u00fcnya \u00e7ap\u0131nda b\u00fcy\u00fck ara\u015ft\u0131rma kurumlar\u0131n\u0131n dikkatini \u00e7ekiyor.<\/p> <p>Daha fazla e\u011fitim i\u00e7eri\u011fi ve piyasa analizleri i\u00e7in <a href=\"\/blog\">Pocket Option blog<\/a> sayfam\u0131z\u0131 ziyaret edin; karma\u015f\u0131k yat\u0131r\u0131m kavramlar\u0131n\u0131 uygulanabilir stratejilere d\u00f6n\u00fc\u015ft\u00fcr\u00fcyoruz.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Prothena Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2>\n<p>29 A\u011fustos 2025 itibar\u0131yla Prothena Corporation (PRTA), NASDAQ borsas\u0131nda <strong>8,24 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>11 Kas\u0131m 2025<\/strong> kesinlikle kritik\u2014Prothena&#8217;n\u0131n 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih. Tarihsel olarak, bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden oluyor.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 PRTA Hissesini Nas\u0131l Etkiler?<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>4 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>6,81 $<\/td>\n<td>+%1,3 (ertesi g\u00fcn)<\/td>\n<\/tr>\n<tr>\n<td>8 May 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>5,92 $<\/td>\n<td>+%8,2 (bir hafta sonra)<\/td>\n<\/tr>\n<tr>\n<td>20 \u015eub 2025<\/td>\n<td>4. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>7,15 $<\/td>\n<td>-%4,1 (beklentiler kar\u015f\u0131lanmad\u0131)<\/td>\n<\/tr>\n<tr>\n<td>12 Kas 2024<\/td>\n<td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>8,40 $<\/td>\n<td>+%12,7 (beklentiler a\u015f\u0131ld\u0131)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Prothena, kazan\u00e7 beklentileri kar\u015f\u0131lanmad\u0131\u011f\u0131nda bile (\u00f6rne\u011fin 2025 2. \u00e7eyrek -%13,82 sapma) yat\u0131r\u0131mc\u0131lar\u0131n klinik \u00fcr\u00fcn hatt\u0131na olan iyimserli\u011fi sayesinde genellikle h\u0131zl\u0131 toparlanma g\u00f6steriyor.<\/p>\n<h3>6 Ayl\u0131k Fiyat Seyri (Mart-A\u011fustos 2025)<\/h3>\n<p>Prothena hisseleri son d\u00f6rt haftada <strong>%29,7<\/strong> art\u0131\u015fla adeta bir h\u0131z treni ya\u015fad\u0131:<\/p>\n<ul>\n<li><strong>Mart 2025<\/strong>: 5,20 $ (k\u0131\u015f sonras\u0131 konsolidasyon)<\/li>\n<li><strong>May\u0131s 2025<\/strong>: 6,50 $ (1. \u00e7eyrek kazan\u00e7 beklentisi)<\/li>\n<li><strong>Temmuz 2025<\/strong>: 6,30 $ (yaz volatilitesi)<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: 8,24 $ (klinik deneme iyimserli\u011fi)<\/li>\n<\/ul>\n<p><strong>Son y\u00fckseli\u015fin sebebi nedir?<\/strong> \u015eirket, Alzheimer ilac\u0131 PRX012 i\u00e7in umut verici Faz 1 sonu\u00e7lar\u0131n\u0131 a\u00e7\u0131klad\u0131 ve Novo Nordisk ile ileri a\u015fama denemeler i\u00e7in b\u00fcy\u00fck bir ortakl\u0131k taahh\u00fcd\u00fc sa\u011flad\u0131.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p><strong>2025 (Y\u0131l Sonu)<\/strong>: 22-25 $ (klinik d\u00f6n\u00fcm noktalar\u0131 ger\u00e7ekle\u015fmesi) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br \/> <strong>2026<\/strong>: 30-35 $ (ortakl\u0131k gelirlerinin tan\u0131nmas\u0131)<br \/> <strong>2028<\/strong>: 45-55 $ (muhtemel ilk ticari onaylar)<br \/> <strong>2030<\/strong>: 70+ $ (\u00fcr\u00fcn hatt\u0131n\u0131n olgunla\u015fmas\u0131 ve pazar geni\u015flemesi)<\/p>\n<p><strong>Sonu\u00e7<\/strong>: Bu klasik bir biyoteknoloji f\u0131rsat\u0131\u2014y\u00fcksek risk ama sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in ola\u011fan\u00fcst\u00fc \u00f6d\u00fcl potansiyeli.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Deneysel ila\u00e7lar\u0131n %90\u2019\u0131 piyasaya ula\u015fam\u0131yor<\/li>\n<li><strong>Nakit t\u00fcketimi<\/strong>: Y\u0131ll\u0131k 302 milyon $ zarar, s\u0131k fonlama gerektiriyor<\/li>\n<li><strong>Reg\u00fclasyon engelleri<\/strong>: FDA onaylar\u0131 y\u0131llar alabilir ve beklenmedik gecikmeler ya\u015fanabilir<\/li>\n<li><strong>Hisse seyrelmesi<\/strong>: Gelecekteki fonlamalar mevcut hissedarlar\u0131 seyreltebilir<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Novo Nordisk ortakl\u0131\u011f\u0131<\/strong>: \u0130la\u00e7lar\u0131 ileri a\u015fama denemelere ta\u015f\u0131ma taahh\u00fcd\u00fc (<a href=\"https:\/\/ir.prothena.com\/investors\/press-releases\/news-details\/2025\/Prothena-Announces-Corporate-Restructuring\/default.aspx\">Kurumsal Yeniden Yap\u0131lanma Duyurusu<\/a>)<\/li>\n<li><strong>PRX012 at\u0131l\u0131m\u0131<\/strong>: Faz 1 Alzheimer verileri umut veriyor (<a href=\"https:\/\/ir.prothena.com\/investors\/press-releases\/news-details\/2025\/Prothena-Provides-Update-on-PRX012-and-Announces-Results-from-the-Phase-1-ASCENT-Clinical-Program\/default.aspx\">ASCENT Klinik Program\u0131<\/a>)<\/li>\n<li><strong>Analist iyimserli\u011fi<\/strong>: Ortalama fiyat hedefi 30,25 $ ile %267 y\u00fckseli\u015f potansiyeli (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/PRTA\/forecast\/\">MarketBeat Analizi<\/a>)<\/li>\n<li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: N\u00f6rodejeneratif hastal\u0131k pazar\u0131 2028\u2019de 50 milyar $\u2019a ula\u015fmas\u0131 bekleniyor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn sadece %2-3\u2019\u00fcn\u00fc y\u00fcksek riskli biyoteknoloji hisselerine ay\u0131r\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Birka\u00e7 ay boyunca 100-200 $ aras\u0131 al\u0131mlar yap\u0131n<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Daha iyi giri\u015f i\u00e7in 7,50 $ alt\u0131ndaki d\u00fc\u015f\u00fc\u015fleri takip edin<\/li>\n<li><strong>Esprili yakla\u015f\u0131m<\/strong>: &#8220;PRTA ticareti yapmak, dahi bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014y\u0131ld\u00f6n\u00fcm\u00fcn\u00fcz\u00fc unutabilirler ama bir sonraki penisilini ke\u015ffedebilirler!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 Prothena Corporation plc (PRTA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ listeleri ve par\u00e7al\u0131 hisse sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Genellikle 1-2 i\u015f g\u00fcn\u00fc s\u00fcrer<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;PRTA&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>Sadece &#8220;Prothena&#8221; de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Limit emirleri volatilite s\u0131ras\u0131nda a\u015f\u0131r\u0131 \u00f6deme yapman\u0131z\u0131 engeller<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Komisyon \u00fccretlerini kontrol edin\u2014%1\u2019in alt\u0131nda hedefleyin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Pozisyonunuzu izleyin<\/td>\n<td>Al\u0131\u015f fiyat\u0131n\u0131n %20-25 alt\u0131nda stop-loss koyun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in \u00dcst\u00fcn?<\/h2>\n<p>Pocket Option, inan\u0131lmaz eri\u015filebilir yakla\u015f\u0131m\u0131yla \u00f6ne \u00e7\u0131k\u0131yor: <strong>sadece 5 $ minimum depozito<\/strong> ile stratejilerinizi risksiz test etmenizi sa\u011fl\u0131yor. Platform, <strong>1 dakikal\u0131k KYC do\u011frulamas\u0131<\/strong> sunuyor ve tek bir belge ile yap\u0131labiliyor. Ayr\u0131ca <strong>100\u2019den fazla para \u00e7ekme y\u00f6ntemi<\/strong> destekliyor; kripto paralar, e-c\u00fczdanlar ve geleneksel banka transferleri dahil. Bu esneklik, PRTA gibi volatil biyoteknoloji hisselerinde k\u00fc\u00e7\u00fck ba\u015flay\u0131p b\u00fcy\u00fcmek isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in ideal.<\/p>\n<h2>\ud83c\udf0d 2025\u2019te Prothena: N\u00f6robilimde Yenilik\u00e7i<\/h2>\n<p>Prothena Corporation, protein d\u00fczensizli\u011fi uzmanl\u0131\u011f\u0131yla n\u00f6rodejeneratif hastal\u0131k tedavisinde devrim yarat\u0131yor. \u015eirket, Alzheimer, Parkinson ve nadir amiloid hastal\u0131klar\u0131na odaklan\u0131yor ve Bristol Myers Squibb ile Novo Nordisk gibi b\u00fcy\u00fck ila\u00e7 firmalar\u0131yla stratejik ortakl\u0131klar kuruyor.<\/p>\n<p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025\u2019te Prothena ara\u015ft\u0131rma ekibi, Alzheimer hastalar\u0131nda belirli protein katlanma bozukluklar\u0131n\u0131n origami yap\u0131lar\u0131 gibi oldu\u011funu ke\u015ffetti\u2014bu da &#8220;protein origami&#8221; ad\u0131 verilen yeni bir ara\u015ft\u0131rma yakla\u015f\u0131m\u0131na yol a\u00e7t\u0131 ve d\u00fcnya \u00e7ap\u0131nda b\u00fcy\u00fck ara\u015ft\u0131rma kurumlar\u0131n\u0131n dikkatini \u00e7ekiyor.<\/p>\n<p>Daha fazla e\u011fitim i\u00e7eri\u011fi ve piyasa analizleri i\u00e7in <a href=\"\/blog\">Pocket Option blog<\/a> sayfam\u0131z\u0131 ziyaret edin; karma\u015f\u0131k yat\u0131r\u0131m kavramlar\u0131n\u0131 uygulanabilir stratejilere d\u00f6n\u00fc\u015ft\u00fcr\u00fcyoruz.<\/p>\n"},"faq":[{"question":"Prothena Corporation plc (PRTA) hisseleri nereden al\u0131nabilir?","answer":"PRTA hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"PRTA hissesi i\u00e7in \u00f6nerilen yat\u0131r\u0131m stratejisi nedir?","answer":"Yat\u0131r\u0131mc\u0131lar portf\u00f6ylerinin %2-3\u2019\u00fcn\u00fc y\u00fcksek riskli biyoteknoloji hisselerine ay\u0131rmal\u0131, dolar maliyeti ortalamas\u0131 yapmal\u0131 ve fiyat uyar\u0131lar\u0131 kurarak uygun giri\u015f noktalar\u0131n\u0131 takip etmelidir."},{"question":"Prothena\u2019n\u0131n klinik denemeleri hakk\u0131nda ne bilmeliyim?","answer":"Prothena, Alzheimer ve di\u011fer n\u00f6rodejeneratif hastal\u0131klar i\u00e7in yenilik\u00e7i ila\u00e7lar geli\u015ftiriyor. Klinik denemeler y\u00fcksek risk ta\u015f\u0131r ancak ba\u015far\u0131l\u0131 olursa b\u00fcy\u00fck getiri potansiyeli vard\u0131r."},{"question":"Pocket Option platformu yeni yat\u0131r\u0131mc\u0131lar i\u00e7in neden uygundur?","answer":"Pocket Option, d\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC do\u011frulamas\u0131 ve \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ile yeni ba\u015flayanlar i\u00e7in eri\u015filebilir ve esnek bir platform sunar."},{"question":"PRTA hissesinin gelecekteki fiyat beklentileri nelerdir?","answer":"Analistlerin ortalama fiyat hedefi 2030 y\u0131l\u0131na kadar 70 $ ve \u00fczeri olarak \u00f6ng\u00f6r\u00fclmekte olup, bu biyoteknoloji \u015firketi i\u00e7in g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme potansiyeli i\u015faret etmektedir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Prothena Corporation plc (PRTA) hisseleri nereden al\u0131nabilir?","answer":"PRTA hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"PRTA hissesi i\u00e7in \u00f6nerilen yat\u0131r\u0131m stratejisi nedir?","answer":"Yat\u0131r\u0131mc\u0131lar portf\u00f6ylerinin %2-3\u2019\u00fcn\u00fc y\u00fcksek riskli biyoteknoloji hisselerine ay\u0131rmal\u0131, dolar maliyeti ortalamas\u0131 yapmal\u0131 ve fiyat uyar\u0131lar\u0131 kurarak uygun giri\u015f noktalar\u0131n\u0131 takip etmelidir."},{"question":"Prothena\u2019n\u0131n klinik denemeleri hakk\u0131nda ne bilmeliyim?","answer":"Prothena, Alzheimer ve di\u011fer n\u00f6rodejeneratif hastal\u0131klar i\u00e7in yenilik\u00e7i ila\u00e7lar geli\u015ftiriyor. Klinik denemeler y\u00fcksek risk ta\u015f\u0131r ancak ba\u015far\u0131l\u0131 olursa b\u00fcy\u00fck getiri potansiyeli vard\u0131r."},{"question":"Pocket Option platformu yeni yat\u0131r\u0131mc\u0131lar i\u00e7in neden uygundur?","answer":"Pocket Option, d\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC do\u011frulamas\u0131 ve \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ile yeni ba\u015flayanlar i\u00e7in eri\u015filebilir ve esnek bir platform sunar."},{"question":"PRTA hissesinin gelecekteki fiyat beklentileri nelerdir?","answer":"Analistlerin ortalama fiyat hedefi 2030 y\u0131l\u0131na kadar 70 $ ve \u00fczeri olarak \u00f6ng\u00f6r\u00fclmekte olup, bu biyoteknoloji \u015firketi i\u00e7in g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme potansiyeli i\u015faret etmektedir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Prothena Corporation plc (PRTA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Prothena Corporation plc (PRTA) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prothena Corporation plc (PRTA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Prothena Corporation plc (PRTA) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T11:26:58+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Prothena Corporation plc (PRTA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Prothena Corporation plc (PRTA) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-29T11:26:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/\",\"name\":\"Prothena Corporation plc (PRTA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Prothena Corporation plc (PRTA) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"datePublished\":\"2025-08-29T11:26:58+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prothena Corporation plc (PRTA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Prothena Corporation plc (PRTA) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Prothena Corporation plc (PRTA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Prothena Corporation plc (PRTA) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/","og_locale":"tr_TR","og_type":"article","og_title":"Prothena Corporation plc (PRTA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Prothena Corporation plc (PRTA) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-29T11:26:58+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Prothena Corporation plc (PRTA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Prothena Corporation plc (PRTA) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-29T11:26:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/","name":"Prothena Corporation plc (PRTA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Prothena Corporation plc (PRTA) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","datePublished":"2025-08-29T11:26:58+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-prothena-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Prothena Corporation plc (PRTA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Prothena Corporation plc (PRTA) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":358005,"slug":"how-to-buy-prothena-corporation","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/"},"pt_AA":{"locale":"pt_AA","id":358002,"slug":"how-to-buy-prothena-corporation","post_title":"Como comprar a\u00e7\u00f5es da Prothena Corporation plc (PRTA) - Investimento em a\u00e7\u00f5es da Prothena Corporation plc (PRTA)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-prothena-corporation\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/358006","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=358006"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/358006\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334036"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=358006"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=358006"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=358006"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}